Pathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness

References

• Vincent J-L, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, Finfer S, Pelosi P, Brazzi L, Aditianingsih D. et al. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA. 2020;323(15):1478–21. doi:10.1001/jama.2020.2717.
   PubMed Web of Science ®Google Scholar
• Dautzenberg MJD, Wekesa AN, Gniadkowski M, Antoniadou A, Giamarellou H, Petrikkos GL, Skiada A, Brun-Buisson C, Bonten MJM, Derde LPG. et al. The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study. Crit Care Med. 2015;43(6):1170. doi:10.1097/CCM.0000000000001028.
   PubMed Web of Science ®Google Scholar
• Auld SC, Caridi-Scheible M, Blum JM, Robichaux C, Kraft C, Jacob JT, Jabaley CS, Carpenter D, Kaplow R, Hernandez-Romieu AC. et al. ICU and ventilator mortality among critically Ill adults with coronavirus disease 2019*. Crit Care Med. 2020;48(9):e799. doi:10.1097/CCM.0000000000004457.
   PubMed Web of Science ®Google Scholar
• Hiser SL, Fatima A, Ali M, Needham DM. Post-intensive care syndrome (PICS): recent updates. J Intensive Care. 2023;11(1):23. doi:10.1186/s40560-023-00670-7.
   PubMed Web of Science ®Google Scholar
• McDonald D, Ackermann G, Khailova L, Baird C, Heyland D, Kozar R, Lemieux M, Derenski K, King J, Vis-Kampen C. et al. Extreme dysbiosis of the microbiome in critical illness. mSphere. 2016;1(4):e00199–16. doi:10.1128/mSphere.00199-16.
   PubMed Web of Science ®Google Scholar
• Evans T, Ali U, Anderton R, Raby E, Manning L, Litton E. Lower gut dysbiosis and mortality in acute critical illness: a systematic review and meta-analysis. Intensive Care Med Exp. 2023;11(1):6. doi:10.1186/s40635-022-00486-z.
   PubMed Web of Science ®Google Scholar
• Wei R, Chen X, Hu L, He Z, Ouyang X, Liang S, Dai S, Sha W, Chen C. Dysbiosis of intestinal microbiota in critically ill patients and risk of in-hospital mortality. Am J Transl Res. 2021;13:1548–1557.
   PubMed Web of Science ®Google Scholar
• Lamarche D, Johnstone J, Zytaruk N, Clarke F, Hand L, Loukov D, Szamosi JC, Rossi L, Schenck LP, Verschoor CP. et al. Microbial dysbiosis and mortality during mechanical ventilation: a prospective observational study. Respir Res. 2018;19(1):245. doi:10.1186/s12931-018-0950-5.
   PubMedGoogle Scholar
• Schlechte J, Zucoloto, AZ, Yu, IL, Doig, CJ, Dunbar, MJ, McCoy, KD, McDonald, B. Dysbiosis of a microbiota–immune metasystem in critical illness is associated with nosocomial infections. Nat Med. 2023;29(4):1–11. doi:10.1038/s41591-023-02243-5.
   PubMed Web of Science ®Google Scholar
• Hollister EB, Gao C, Versalovic J. Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology. 2014;146(6):1449–1458. doi:10.1053/j.gastro.2014.01.052.
   PubMed Web of Science ®Google Scholar
• Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–214.
   PubMed Web of Science ®Google Scholar
• Ravi A, Halstead FD, Bamford A, Casey A, Thomson NM, van Schaik W, Snelson C, Goulden R, Foster-Nyarko E, Savva GM. et al. Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients. Microb Genomics. 2019;5(9):e000293. doi:10.1099/mgen.0.000293.
   PubMed Web of Science ®Google Scholar
• Zaborin A, Smith D, Garfield K, Quensen J, Shakhsheer B, Kade M, Tirrell M, Tiedje J, Gilbert JA, Zaborina O. et al. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness. mBio. 2014;5(5):e01361–14. doi:10.1128/mBio.01361-14.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li N, Fang H, Chen X, Guo Y, Gong S, Niu M, Zhou H, Jiang Y, Chang P. et al. Enteric dysbiosis is associated with sepsis in patients. Faseb J. 2019;33(11):12299–12310. doi:10.1096/fj.201900398RR.
   PubMed Web of Science ®Google Scholar
• Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis. Science. 2013;341(6145):569–573. doi:10.1126/science.1241165.
   PubMed Web of Science ®Google Scholar
• Lankelma JM, van Vught LA, Belzer C, Schultz MJ, van der Poll T, de Vos WM, Wiersinga WJ. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study. Intensive Care Med. 2017;43(1):59–68. doi:10.1007/s00134-016-4613-z.
   PubMed Web of Science ®Google Scholar
• Lankelma JM, Cranendonk DR, Belzer C, de Vos AF, de Vos WM, van der Poll T, Wiersinga WJ. Antibiotic-induced gut microbiota disruption during human endotoxemia: a randomised controlled study. Gut. 2017;66(9):1623–1630. doi:10.1136/gutjnl-2016-312132.
   PubMed Web of Science ®Google Scholar
• Ojima M, Shimizu K, Motooka D, Ishihara T, Nakamura S, Shintani A, Ogura H, Iida T, Yoshiya K, Shimazu T. et al. Gut dysbiosis associated with antibiotics and disease severity and its relation to mortality in critically Ill patients. Dig Dis Sci. 2022;67(6):2420–2432. doi:10.1007/s10620-021-07000-7.
   PubMed Web of Science ®Google Scholar
• Szychowiak P, Villageois-Tran K, Patrier J, Timsit J-F, Ruppé É. The role of the microbiota in the management of intensive care patients. Ann Intensive Care. 2022;12(3). doi:10.1186/s13613-021-00976-5.
   PubMedGoogle Scholar
• Iapichino G, Callegari ML, Marzorati S, Cigada M, Corbella D, Ferrari S, Morelli L. Impact of antibiotics on the gut microbiota of critically ill patients. J Med Microbiol. 2008;57(8):1007–1014. doi:10.1099/jmm.0.47387-0.
   PubMed Web of Science ®Google Scholar
• Agudelo-Ochoa GM, Valdés-Duque BE, Giraldo-Giraldo NA, Jaillier-Ramírez AM, Giraldo-Villa A, Acevedo-Castaño I, Yepes-Molina MA, Barbosa-Barbosa J, Benítez-Paéz A. Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis. Gut Microbes. 2020;12(1):1707610. doi:10.1080/19490976.2019.1707610.
   PubMed Web of Science ®Google Scholar
• Haak BW, Argelaguet R, Kinsella CM, Kullberg RFJ, Lankelma JM, Deijs M, Klein M, Jebbink MF, Hugenholtz F, Kostidis S. et al. Integrative transkingdom analysis of the gut microbiome in antibiotic perturbation and critical illness. mSystems. 2021;6(2):e01148–20. doi:10.1128/mSystems.01148-20.
   PubMed Web of Science ®Google Scholar
• Hayakawa M, Asahara T, Henzan N, Murakami H, Yamamoto H, Mukai N, Minami Y, Sugano M, Kubota N, Uegaki S. et al. Dramatic changes of the gut flora immediately after severe and sudden insults. Dig Dis Sci. 2011;56(8):2361–2365. doi:10.1007/s10620-011-1649-3.
   PubMed Web of Science ®Google Scholar
• Livanos AE, Snider EJ, Whittier S, Chong DH, Wang TC, Abrams JA, Freedberg DE. Rapid gastrointestinal loss of clostridial clusters IV and XIVa in the ICU associates with an expansion of gut pathogens. PLOS One. 2018;13(8):e0200322. doi:10.1371/journal.pone.0200322.
   PubMed Web of Science ®Google Scholar
• Freedberg DE, Zhou MJ, Cohen ME, Annavajhala MK, Khan S, Moscoso DI, Brooks C, Whittier S, Chong DH, Uhlemann A-C. et al. Pathogen colonization of the gastrointestinal microbiome at intensive care unit admission and risk for subsequent death or infection. Intensive Care Med. 2018;44(8):1203–1211. doi:10.1007/s00134-018-5268-8.
   PubMed Web of Science ®Google Scholar
• Chanderraj R, Baker JM, Kay SG, Brown CA, Hinkle KJ, Fergle DJ, McDonald RA, Falkowski NR, Metcalf JD, Kaye KS. et al. In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes. Eur Respir J. 2023;61(2):2200910. doi:10.1183/13993003.00910-2022.
   PubMed Web of Science ®Google Scholar
• McDonald EG, Milligan J, Frenette C, Lee TC. Continuous proton pump inhibitor therapy and the associated risk of recurrent clostridium difficile infection. JAMA Internal Medicine. 2015;175(5):784–791. doi:10.1001/jamainternmed.2015.42.
   PubMed Web of Science ®Google Scholar
• Lassalle M, Zureik M, Dray-Spira R. Proton pump inhibitor use and risk of serious infections in young children. JAMA Pediatr. 2023;177(10):1028–1038. doi:10.1001/jamapediatrics.2023.2900.
   PubMed Web of Science ®Google Scholar
• Adike A, Quigley EMM. Gastrointestinal motility problems in critical care: a clinical perspective. J Dig Dis. 2014;15(7):335–344. doi:10.1111/1751-2980.12147.
   PubMed Web of Science ®Google Scholar
• Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth. Gastroenterol Hepatol. 2007;3:112–122.
   PubMedGoogle Scholar
• Karakosta A, Bousvaros K, Margaritis A, Moschovi P, Mousafiri O, Fousekis F, Papathanakos G, Samara E, Tzimas P, Christodoulou D. et al. High prevalence of small intestinal bacterial overgrowth syndrome in ICU patients: an observational study. J Intensive Care Med. 2024;39(1):69–76. doi:10.1177/08850666231190284.
   PubMed Web of Science ®Google Scholar
• Chang C, Lin H. Dysbiosis in gastrointestinal disorders. Best Pract Res Clin Gastroenterol. 2016;30(1):3–15. doi:10.1016/j.bpg.2016.02.001.
   PubMed Web of Science ®Google Scholar
• Ladopoulos T, Giannaki M, Alexopoulou C, Proklou A, Pediaditis E, Kondili E. Gastrointestinal dysmotility in critically ill patients. Ann Gastroenterol. 2018;31:273–281. doi:10.20524/aog.2018.0250.
   PubMedGoogle Scholar
• Joffre J, Lloyd E, Wong E, Chung-Yeh C, Nguyen N, Xu F, Legrand M, Hellman J. Catecholaminergic vasopressors reduce toll-like receptor agonist-induced microvascular endothelial cell permeability but not cytokine production. Crit Care Med. 2021;49(3):e315–e326. doi:10.1097/CCM.0000000000004854.
   PubMed Web of Science ®Google Scholar
• Zeng MY, Inohara N, Nuñez G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 2017;10(1):18–26. doi:10.1038/mi.2016.75.
   PubMed Web of Science ®Google Scholar
• Pamer EG. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science. 2016;352(6285):535–538. doi:10.1126/science.aad9382.
   PubMed Web of Science ®Google Scholar
• Sorbara MT, Dubin K, Littmann ER, Moody TU, Fontana E, Seok R, Leiner IM, Taur Y, Peled JU, van den Brink MRM. et al. Inhibiting antibiotic-resistant enterobacteriaceae by microbiota-mediated intracellular acidification. J Exp Med. 2018;216(1):84–98. doi:10.1084/jem.20181639.
   PubMed Web of Science ®Google Scholar
• Sorbara MT, Pamer EG. Interbacterial mechanisms of colonization resistance and the strategies pathogens use to overcome them. Mucosal Immunol. 2019;12(1):1–9. doi:10.1038/s41385-018-0053-0.
   PubMed Web of Science ®Google Scholar
• Kamada N, Kim Y-G, Sham HP, Vallance BA, Puente JL, Martens EC, Núñez G. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science. 2012;336(6086):1325–1329. doi:10.1126/science.1222195.
   PubMed Web of Science ®Google Scholar
• Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A, Lee YJ, Dubin KA, Socci ND, Viale A. et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;55(7):905–914. doi:10.1093/cid/cis580.
   PubMed Web of Science ®Google Scholar
• Kim SG, Becattini S, Moody TU, Shliaha PV, Littmann ER, Seok R, Gjonbalaj M, Eaton V, Fontana E, Amoretti L. et al. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant enterococcus. Nature. 2019;572(7771):665–669. doi:10.1038/s41586-019-1501-z.
   PubMed Web of Science ®Google Scholar
• Caballero S, Kim S, Carter RA, Leiner IM, Sušac B, Miller L, Kim GJ, Ling L, Pamer EG. Cooperating commensals restore colonization resistance to vancomycin-resistant enterococcus faecium. Cell Host Microbe. 2017;21(5):592–602.e4. doi:10.1016/j.chom.2017.04.002.
   PubMed Web of Science ®Google Scholar
• Orieux A, Enaud R, Imbert S, Boyer P, Begot E, Camino A, Boyer A, Berger P, Gruson D, Delhaes L. et al. The gut microbiota composition is linked to subsequent occurrence of ventilator-associated pneumonia in critically ill patients. Microbiol Spectr. 2023;11(5):e0064123. doi:10.1128/spectrum.00641-23.
   PubMed Web of Science ®Google Scholar
• Frencken JF, Wittekamp BHJ, Plantinga NL, Spitoni C, van de Groep K, Cremer OL, Bonten MJM. Associations between enteral colonization with gram-negative bacteria and intensive care unit–acquired infections and colonization of the respiratory tract. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018;66(4):497–503. doi:10.1093/cid/cix824.
   PubMed Web of Science ®Google Scholar
• Torres A, Dorca J, Zalacaín R, Bello S, El-Ebiary M, Molinos L, Arévalo M, Blanquer J, Celis R, Iriberri M. et al. Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. Am J Respir Crit Care Med. 1996;154(5):1456–1461. doi:10.1164/ajrccm.154.5.8912764.
   PubMed Web of Science ®Google Scholar
• Kallel H, Houcke S, Resiere D, Court T, Roncin C, Raad M, Nkontcho F, Demar M, Pujo J, Hommel D. et al. Prior carriage predicts intensive care unit infections caused by extended-spectrum beta-lactamase–producing enterobacteriaceae. Am J Trop Med Hyg. 2022;106(2):525–531. doi:10.4269/ajtmh.20-1436.
   PubMed Web of Science ®Google Scholar
• Jung E, Byun S, Lee H, Moon SY, Lee H. Vancomycin-resistant enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization. Am J Infect Control. 2014;42(10):1062–1066. doi:10.1016/j.ajic.2014.06.024.
   PubMed Web of Science ®Google Scholar
• Tamburini FB, Andermann TM, Tkachenko E, Senchyna F, Banaei N, Bhatt AS. Precision identification of diverse bloodstream pathogens in the gut microbiome. Nat Med. 2018;24(12):1809–1814. doi:10.1038/s41591-018-0202-8.
   PubMed Web of Science ®Google Scholar
• Stoma I, Littmann ER, Peled JU, Giralt S, van den Brink MRM, Pamer EG, Taur Y. Compositional flux within the intestinal microbiota and risk for bloodstream infection with gram-negative bacteria. Clin Infect Dis Off Publ Infect Dis Soc Am. 2021;73(11):e4627–e4635. doi:10.1093/cid/ciaa068.
   PubMed Web of Science ®Google Scholar
• Bernard-Raichon L, Venzon M, Klein J, Axelrad JE, Zhang C, Sullivan AP, Hussey GA, Casanovas-Massana A, Noval MG, Valero-Jimenez AM. et al. Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nat Commun. 2022;13(1):5926. doi:10.1038/s41467-022-33395-6.
   PubMed Web of Science ®Google Scholar
• Schwartz DJ, Shalon N, Wardenburg K, DeVeaux A, Wallace MA, Hall-Moore C, Ndao IM, Sullivan JE, Radmacher P, Escobedo M. et al. Gut pathogen colonization precedes bloodstream infection in the neonatal intensive care unit. Sci Transl Med. 2023;15(694):eadg5562. doi:10.1126/scitranslmed.adg5562.
   PubMed Web of Science ®Google Scholar
• Andremont O, Armand-Lefevre L, Dupuis C, de Montmollin E, Ruckly S, Lucet J-C, Smonig R, Magalhaes E, Ruppé E, Mourvillier B. et al. Semi-quantitative cultures of throat and rectal swabs are efficient tests to predict ESBL-Enterobacterales ventilator-associated pneumonia in mechanically ventilated ESBL carriers. Intensive Care Med. 2020;46(6):1232–1242. doi:10.1007/s00134-020-06029-y.
   PubMed Web of Science ®Google Scholar
• Yue C, Ma B, Zhao Y, Li Q, Li J. Lipopolysaccharide-induced bacterial translocation is intestine site-specific and associates with intestinal mucosal inflammation. Inflammation. 2012;35(6):1880–1888. doi:10.1007/s10753-012-9510-1.
   PubMed Web of Science ®Google Scholar
• Gómez-Hurtado I, Santacruz A, Peiró G, Zapater P, Gutiérrez A, Pérez-Mateo M, Sanz Y, Francés R. Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis. PLoS One. 2011;6(7):e23037. doi:10.1371/journal.pone.0023037.
   PubMed Web of Science ®Google Scholar
• Knoop KA, McDonald KG, Kulkarni DH, Newberry RD. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut. 2016;65(7):1100–1109. doi:10.1136/gutjnl-2014-309059.
   PubMed Web of Science ®Google Scholar
• Blijlevens NMA, Donnelly JP, de Pauw BE. Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant. Bone Marrow Transplant. 2005;35(7):707–711. doi:10.1038/sj.bmt.1704863.
   PubMed Web of Science ®Google Scholar
• Zhai B, Ola M, Rolling T, Tosini NL, Joshowitz S, Littmann ER, Amoretti LA, Fontana E, Wright RJ, Miranda E. et al. High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis. Nat Med. 2020;26(1):59–64. doi:10.1038/s41591-019-0709-7.
   PubMed Web of Science ®Google Scholar
• Montassier E, Kitsios GD, Radder JE, Le Bastard Q, Kelly BJ, Panzer A, Lynch SV, Calfee CS, Dickson RP, Roquilly A. et al. Robust airway microbiome signatures in acute respiratory failure and hospital-acquired pneumonia. Nat Med. 2023;29(11):2793–2804. doi:10.1038/s41591-023-02617-9.
   PubMed Web of Science ®Google Scholar
• Kitsios GD, Fitch A, Manatakis DV, Rapport SF, Li K, Qin S, Huwe J, Zhang Y, Doi Y, Evankovich J. et al. Respiratory microbiome profiling for etiologic diagnosis of pneumonia in mechanically ventilated patients. Front Microbiol. 2018;9:1413. doi:10.3389/fmicb.2018.01413.
   PubMed Web of Science ®Google Scholar
• Stanley D, Mason LJ, Mackin KE, Srikhanta YN, Lyras D, Prakash MD, Nurgali K, Venegas A, Hill MD, Moore RJ. et al. Translocation and dissemination of commensal bacteria in post-stroke infection. Nat Med. 2016;22(11):1277–1284. doi:10.1038/nm.4194.
   PubMed Web of Science ®Google Scholar
• Dickson RP, Singer BH, Newstead MW, Falkowski NR, Erb-Downward JR, Standiford TJ, Huffnagle GB. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat Microbiol. 2016;1(10):16113. doi:10.1038/nmicrobiol.2016.113.
   PubMed Web of Science ®Google Scholar
• Johnstone J, Meade M, Lauzier F, Marshall J, Duan E, Dionne J, Arabi YM, Heels-Ansdell D, Thabane L, Lamarche D. et al. Effect of probiotics on incident ventilator-associated pneumonia in critically Ill patients: a randomized clinical trial. JAMA. 2021;326(11):1024–1033. doi:10.1001/jama.2021.13355.
   PubMed Web of Science ®Google Scholar
• Sommerstein R, Merz TM, Berger S, Kraemer JG, Marschall J, Hilty M. Patterns in the longitudinal oropharyngeal microbiome evolution related to ventilator-associated pneumonia. Antimicrob Resist Infect Control. 2019;8(1):81. doi:10.1186/s13756-019-0530-6.
   PubMed Web of Science ®Google Scholar
• Emonet S, Lazarevic V, Leemann Refondini C, Gaïa N, Leo S, Girard M, Nocquet Boyer V, Wozniak H, Després L, Renzi G. et al. Identification of respiratory microbiota markers in ventilator-associated pneumonia. Intensive Care Med. 2019;45(8):1082–1092. doi:10.1007/s00134-019-05660-8.
   PubMed Web of Science ®Google Scholar
• de Castilhos J, Zamir E, Hippchen T, Rohrbach R, Schmidt S, Hengler S, Schumacher H, Neubauer M, Kunz S, Müller-Esch T. et al. Severe dysbiosis and specific haemophilus and neisseria signatures as hallmarks of the oropharyngeal microbiome in critically Ill coronavirus disease 2019 (COVID-19) patients. Clin Infect Dis. 2022;75(1):e1063–e1071. doi:10.1093/cid/ciab902.
   PubMed Web of Science ®Google Scholar
• Forslund K, Sunagawa S, Kultima JR, Mende DR, Arumugam M, Typas A, Bork P. Country-specific antibiotic use practices impact the human gut resistome. Genome Res. 2013;23(7):1163–1169. doi:10.1101/gr.155465.113.
   PubMed Web of Science ®Google Scholar
• Hu Y, Yang X, Qin J, Lu N, Cheng G, Wu N, Pan Y, Li J, Zhu L, Wang X. et al. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat Commun. 2013;4(1):2151. doi:10.1038/ncomms3151.
   PubMedGoogle Scholar
• Razazi K, Mekontso Dessap A, Carteaux G, Jansen C, Decousser J-W, de Prost N, Brun-Buisson C. Frequency, associated factors and outcome of multi-drug-resistant intensive care unit-acquired pneumonia among patients colonized with extended-spectrum β-lactamase-producing enterobacteriaceae. Ann Intensive Care. 2017;7(1):61. doi:10.1186/s13613-017-0283-4.
   PubMedGoogle Scholar
• Bottazzi A, Nattino G, Tascini C, Poole D, Viaggi B, Carrara G, Rossi C, Crespi D, Mondini M, Langer M. et al. Mortality attributable to different klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection. Intensive Care Med. 2018;44(10):1709–1719. doi:10.1007/s00134-018-5360-0.
   PubMed Web of Science ®Google Scholar
• Lakbar I, Medam S, Ronflé R, Cassir N, Delamarre L, Hammad E, Lopez A, Lepape A, Machut A, Boucekine M. et al. Association between mortality and highly antimicrobial-resistant bacteria in intensive care unit-acquired pneumonia. Sci Rep. 2021;11(1):16497. doi:10.1038/s41598-021-95852-4.
   PubMed Web of Science ®Google Scholar
• Zhen X, Lundborg CS, Sun X, Hu X, Dong H. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrob Resist Infect Control. 2019;8(1):137. doi:10.1186/s13756-019-0590-7.
   PubMed Web of Science ®Google Scholar
• Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, Viale A, Socci ND, van den Brink MRM, Kamboj M. et al. Vancomycin-resistant enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest. 2010;120(12):4332–4341. doi:10.1172/JCI43918.
   PubMed Web of Science ®Google Scholar
• Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, Hutton-Thomas RA, Whalen CC, Bonomo RA, Rice LB. et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med. 2000;343(26):1925–1932. doi:10.1056/NEJM200012283432604.
   PubMed Web of Science ®Google Scholar
• Kim S, Covington A, Pamer EG. The intestinal microbiota: antibiotics, colonization resistance, and enteric pathogens. Immunol Rev. 2017;279(1):90–105. doi:10.1111/imr.12563.
   PubMed Web of Science ®Google Scholar
• Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, Schnabl B, DeMatteo RP, Pamer EG. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature. 2008;455(7214):804–807. doi:10.1038/nature07250.
   PubMed Web of Science ®Google Scholar
• Daneman N, Sarwar S, Fowler RA, Cuthbertson BH, SuDDICU Canadian Study Group. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(4):328–341. doi:10.1016/S1473-3099(12)70322-5.
   PubMed Web of Science ®Google Scholar
• Connor CH, Zucoloto AZ, Munnoch JT, Yu I-L, Corander J, Hoskisson PA, McDonald B, McNally A. Multidrug-resistant E. coli encoding high genetic diversity in carbohydrate metabolism genes displace commensal E. coli from the intestinal tract. PLOS Biol. 2023;21(10):e3002329. doi:10.1371/journal.pbio.3002329.
   PubMed Web of Science ®Google Scholar
• Duggal NA, Snelson C, Shaheen U, Pearce V, Lord JM. Innate and adaptive immune dysregulation in critically ill ICU patients. Sci Rep. 2018;8(1):10186. doi:10.1038/s41598-018-28409-7.
   PubMedGoogle Scholar
• Pfortmueller CA, Meisel C, Fux M, Schefold JC. Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers. Intensive Care Med Exp. 2017;5(1):49. doi:10.1186/s40635-017-0163-0.
   PubMedGoogle Scholar
• Tremblay J-A, Peron F, Kreitmann L, Textoris J, Brengel-Pesce K, Lukaszewicz A-C, Quemeneur L, Vedrine C, Tan LK, Venet F. et al. A stratification strategy to predict secondary infection in critical illness-induced immune dysfunction: the REALIST score. Ann Intensive Care. 2022;12(1):76. doi:10.1186/s13613-022-01051-3.
   PubMed Web of Science ®Google Scholar
• Ansaldo E, Farley TK, Belkaid Y. Control of immunity by the microbiota. Annu Rev Immunol. 2021;39(1):449–479. doi:10.1146/annurev-immunol-093019-112348.
   PubMed Web of Science ®Google Scholar
• Schlechte J, Skalosky I, Geuking MB, McDonald B. Long-distance relationships – regulation of systemic host defense against infections by the gut microbiota. Mucosal Immunol. 2022;15(5):809–818. doi:10.1038/s41385-022-00539-2.
   PubMed Web of Science ®Google Scholar
• Miniet AA, Grunwell JR, Coopersmith CM. The microbiome and the immune system in critical illness. Curr Opin Crit Care. 2021;27(2):157–163. doi:10.1097/MCC.0000000000000800.
   PubMed Web of Science ®Google Scholar
• Schirmer M, Smeekens SP, Vlamakis H, Jaeger M, Oosting M, Franzosa EA, Ter Horst R, Jansen T, Jacobs L, Bonder MJ. et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell. 2016;167(4):1125–1136.e8. doi:10.1016/j.cell.2016.10.020.
   PubMed Web of Science ®Google Scholar
• Schluter J, Peled JU, Taylor BP, Markey KA, Smith M, Taur Y, Niehus R, Staffas A, Dai A, Fontana E. et al. The gut microbiota is associated with immune cell dynamics in humans. Nature. 2020;588(7837):303–307. doi:10.1038/s41586-020-2971-8.
   PubMed Web of Science ®Google Scholar
• Marshall JC. The multiple organ dysfunction syndrome. In: Holzheimer RG, Mannick JA, editors. Surgical treatment: evidence-based and problem-oriented. Zuckschwerdt; 2001.
   Google Scholar
• Doig CJ, Sutherland L, Dean Sandham J, Fick G, Verhoef M, Meddings J. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically Ill ICU patients. Am J Respir Crit Care Med. 1998;158(2):444–451. doi:10.1164/ajrccm.158.2.9710092.
   PubMed Web of Science ®Google Scholar
• Schroeder BO, Bäckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016;22(10):1079–1089. doi:10.1038/nm.4185.
   PubMed Web of Science ®Google Scholar
• Dang AT, Marsland BJ. Microbes, metabolites, and the gut–lung axis. Mucosal Immunol. 2019;12(4):843–850. doi:10.1038/s41385-019-0160-6.
   PubMed Web of Science ®Google Scholar
• Nath S, Kitsios GD, Bos LDJ. Gut–lung crosstalk during critical illness. Curr Opin Crit Care. 2023;29(2):130–137. doi:10.1097/MCC.0000000000001015.
   PubMed Web of Science ®Google Scholar
• Kelly BJ, Imai I, Bittinger K, Laughlin A, Fuchs BD, Bushman FD, Collman RG. Composition and dynamics of the respiratory tract microbiome in intubated patients. Microbiome. 2016;4(7). doi:10.1186/s40168-016-0151-8.
   PubMedGoogle Scholar
• Ely EW, Shintani, A, Truman, B, Speroff, T, Gordon, SM, Harrell Jr, Frank E, Inouye, SK, Bernard, GR, Dittus, RS Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291(14):1753–1762. doi:10.1001/jama.291.14.1753.
   PubMed Web of Science ®Google Scholar
• Ely E, Gautam S, Margolin R, Francis J, May L, Speroff T, Truman B, Dittus R, Bernard G, Inouye S. et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001;27(12):1892–1900. doi:10.1007/s00134-001-1132-2.
   PubMed Web of Science ®Google Scholar
• Garcez FB, Garcia de Alencar JC, Fernandez SSM, Avelino-Silva VI, Sabino EC, Martins RCR, Franco LAM, Lima Ribeiro SM, Possolo de Souza H, Avelino-Silva TJ. et al. Association between gut microbiota and delirium in acutely Ill older adults. J Gerontol Ser A. 2023;78(8):1320–1327. doi:10.1093/gerona/glad074.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhai H, Geng J, Yu R, Ren H, Fan H, Shi P. Large-scale survey of gut microbiota associated with MHE via 16S rRNA-based pyrosequencing. Am J Gastroenterol. 2013;108(10):1601–1611. doi:10.1038/ajg.2013.221.
   PubMed Web of Science ®Google Scholar
• Wijdicks EFM, Longo DL. Hepatic encephalopathy. N Engl J Med. 2016;375(17):1660–1670. doi:10.1056/NEJMra1600561.
   PubMed Web of Science ®Google Scholar
• Yang J, Kim CJ, Go YS, Lee HY, Kim M-G, Oh SW, Cho WY, Im S-H, Jo SK. Intestinal microbiota control acute kidney injury severity by immune modulation. Kidney Int. 2020;98(4):932–946. doi:10.1016/j.kint.2020.04.048.
   PubMed Web of Science ®Google Scholar
• Lei J, Xie Y, Sheng J, Song J. Intestinal microbiota dysbiosis in acute kidney injury: novel insights into mechanisms and promising therapeutic strategies. Ren Fail. 2022;44(1):571–580. doi:10.1080/0886022X.2022.2056054.
   PubMed Web of Science ®Google Scholar
• Schneider KM, Elfers C, Ghallab A, Schneider CV, Galvez EJC, Mohs A, Gui W, Candels LS, Wirtz TH, Zuehlke S. et al. Intestinal dysbiosis amplifies acetaminophen-induced acute liver injury. Cell Mol Gastroenterol Hepatol. 2021;11(4):909–933. doi:10.1016/j.jcmgh.2020.11.002.
   PubMed Web of Science ®Google Scholar
• Chen Y, Guo J, Qian G, Fang D, Shi D, Guo L, Li L. Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality. J Gastroenterol Hepatol. 2015;30(9):1429–1437. doi:10.1111/jgh.12932.
   PubMed Web of Science ®Google Scholar
• Violi F, Pignatelli P, Castellani V, Carnevale R, Cammisotto V. Gut dysbiosis, endotoxemia and clotting activation: a dangerous trio for portal vein thrombosis in cirrhosis. Blood Rev. 2023;57:100998. doi:10.1016/j.blre.2022.100998.
   PubMed Web of Science ®Google Scholar
• Buelow E, Bello González TDJ, Fuentes S, de Steenhuijsen Piters WAA, Lahti L, Bayjanov JR, Majoor EAM, Braat JC, van Mourik MSM, Oostdijk EAN. et al. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects. Microbiome. 2017;5(1):88. doi:10.1186/s40168-017-0309-z.
   PubMedGoogle Scholar
• van Doorn-Schepens MLM, Abis GSA, Oosterling SJ, van Egmond M, Poort L, Stockmann HBAC, Bonjer HJ, Savelkoul PHM, Budding AE. The effect of selective decontamination on the intestinal microbiota as measured with IS-pro: a taxonomic classification tool applicable for direct evaluation of intestinal microbiota in clinical routine. Eur J Clin Microbiol Infect Dis. 2022;41(11):1337–1345. doi:10.1007/s10096-022-04483-8.
   PubMed Web of Science ®Google Scholar
• Hammond NE, Myburgh J, Seppelt I, Garside T, Vlok R, Mahendran S, Adigbli D, Finfer S, Gao Y, Goodman F. et al. Association between selective decontamination of the digestive tract and In-hospital mortality in intensive care unit patients receiving mechanical ventilation: a systematic review and meta-analysis. JAMA. 2022;328(19):1922–1934. doi:10.1001/jama.2022.19709.
   PubMed Web of Science ®Google Scholar
• Plantinga NL, de Smet AMGA, Oostdijk EAN, de Jonge E, Camus C, Krueger WA, Bergmans D, Reitsma JB, Bonten MJM. Selective digestive and oropharyngeal decontamination in medical and surgical ICU patients: individual patient data meta-analysis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2018;24(5):505–513. doi:10.1016/j.cmi.2017.08.019.
   PubMed Web of Science ®Google Scholar
• Boschert C, Broadfield E, Chimunda T, Fletcher J, Knott C, Porwal S, Smith J, Bhonagiri D, Leijten M, Narayan S. et al. Effect of selective decontamination of the digestive tract on hospital mortality in critically Ill patients receiving mechanical ventilation: a randomized clinical trial. JAMA. 2022;328(19):1911–1921. doi:10.1001/jama.2022.17927.
   PubMed Web of Science ®Google Scholar
• Wittekamp BH, Plantinga NL, Cooper BS, Lopez-Contreras J, Coll P, Mancebo J, Wise MP, Morgan MPG, Depuydt P, Boelens J. et al. Decontamination strategies and bloodstream infections with antibiotic-resistant microorganisms in ventilated patients: a randomized clinical trial. JAMA. 2018;320(20):2087–2098. doi:10.1001/jama.2018.13765.
   PubMed Web of Science ®Google Scholar
• Oostdijk EAN, Kesecioglu J, Schultz MJ, Visser CE, de Jonge E, van Essen EHR, Bernards AT, Purmer I, Brimicombe R, Bergmans D. et al. Notice of retraction and replacement: oostdijk et al. Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial. JAMA. 2014;312(14):1429–1437. doi:10.1001/jama.2014.7247.
   PubMed Web of Science ®Google Scholar
• François B, Cariou A, Clere-Jehl R, Dequin P-F, Renon-Carron F, Daix T, Guitton C, Deye N, Legriel S, Plantefève G. et al. Prevention of early ventilator-associated pneumonia after cardiac arrest. N Engl J Med. 2019;381(19):1831–1842. doi:10.1056/NEJMoa1812379.
   PubMed Web of Science ®Google Scholar
• Ehrmann S, Barbier F, Demiselle J, Quenot J-P, Herbrecht J-E, Roux D, Lacherade J-C, Landais M, Seguin P, Schnell D. et al. Inhaled amikacin to prevent ventilator-associated pneumonia. N Engl J Med. 2023;389(22):2052–2062. doi:10.1056/NEJMoa2310307.
   PubMed Web of Science ®Google Scholar
• Wang K, Zeng Q, Li KX, Wang Y, Wang L, Sun MW, Zeng J, Jiang H. Efficacy of probiotics or synbiotics for critically ill adult patients: a systematic review and meta-analysis of randomized controlled trials. Burns Trauma. 2022;10:tkac004. doi:10.1093/burnst/tkac004.
   PubMed Web of Science ®Google Scholar
• Li C, Liu L, Gao Z, Zhang J, Chen H, Ma S, Liu A, Mo M, Wu C, Chen D. et al. Synbiotic therapy prevents nosocomial infection in critically Ill adult patients: a systematic review and network meta-analysis of randomized controlled trials based on a bayesian framework. Front Med. 2021;8:693188. doi:10.3389/fmed.2021.693188.
   Web of Science ®Google Scholar
• Lou J, Cui S, Huang N, Jin G, Chen C, Fan Y, Zhang C, Li J. Efficacy of probiotics or synbiotics in critically ill patients: a systematic review and meta-analysis. Clin Nutr ESPEN. 2024;59:48–62. doi:10.1016/j.clnesp.2023.11.003.
   PubMed Web of Science ®Google Scholar
• Manzanares W, Lemieux M, Langlois PL, Wischmeyer PE. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit Care. 2016;20(1):262. doi:10.1186/s13054-016-1434-y.
   Google Scholar
• Yelin I, Flett KB, Merakou C, Mehrotra P, Stam J, Snesrud E, Hinkle M, Lesho E, McGann P, McAdam AJ. et al. Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients. Nat Med. 2019;25(11):1728–1732. doi:10.1038/s41591-019-0626-9.
   PubMed Web of Science ®Google Scholar
• Fu Y, Moscoso DI, Porter J, Krishnareddy S, Abrams JA, Seres D, Chong DH, Freedberg DE. Relationship between dietary fiber intake and short-chain fatty acid–producing bacteria during critical illness: a prospective cohort study. JPEN J Parenter Enteral Nutr. 2020;44(3):463–471. doi:10.1002/jpen.1682.
   PubMed Web of Science ®Google Scholar
• Seifi N, Sedaghat A, Nematy M, Khadem‐Rezaiyan M, Shirazinezhad R, Ranjbar G, Safarian M. Effects of synbiotic supplementation on the serum endotoxin level, inflammatory status, and clinical outcomes of adult patients with critical illness: a randomized controlled trial. Nutr Clin Pract. 2022;37(2):451–458. doi:10.1002/ncp.10758.
   PubMed Web of Science ®Google Scholar
• Li Q, Wang C, Tang C, He Q, Zhao X, Li N, Li J. Successful treatment of severe sepsis and diarrhea after vagotomy utilizing fecal microbiota transplantation: a case report. Crit Care. 2015;19(1):37. doi:10.1186/s13054-015-0738-7.
   PubMedGoogle Scholar
• Wei Y, Yang J, Wang J, Yang Y, Huang J, Gong H, Cui H, Chen D. Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis. Crit Care. 2016;20(1):332. doi:10.1186/s13054-016-1491-2.
   PubMedGoogle Scholar
• Wurm P, Spindelboeck W, Krause R, Plank J, Fuchs G, Bashir M, Petritsch W, Halwachs B, Langner C, Högenauer C. et al. Antibiotic-associated apoptotic enterocolitis in the absence of a defined pathogen: the role of intestinal microbiota depletion*. Crit Care Med. 2017;45(6):e600–e606. doi:10.1097/CCM.0000000000002310.
   PubMed Web of Science ®Google Scholar
• Li Q, Wang C, Tang C, He Q, Zhao X, Li N, Li J. Therapeutic modulation and reestablishment of the intestinal microbiota with fecal microbiota transplantation resolves sepsis and diarrhea in a patient. Off J Am Coll Gastroenterol ACG. 2014;109(11):1832. doi:10.1038/ajg.2014.299.
   PubMed Web of Science ®Google Scholar
• Dai M, Liu Y, Chen W, Buch H, Shan Y, Chang L, Bai Y, Shen C, Zhang X, Huo Y. et al. Rescue fecal microbiota transplantation for antibiotic-associated diarrhea in critically ill patients. Crit Care. 2019;23(1):1–11. doi:10.1186/s13054-019-2604-5.
   PubMed Web of Science ®Google Scholar
• DeFilipp Z, Bloom PP, Torres Soto M, Mansour MK, Sater MRA, Huntley MH, Turbett S, Chung RT, Chen Y-B, Hohmann EL. et al. Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med. 2019;381(21):2043–2050. doi:10.1056/NEJMoa1910437.
   PubMed Web of Science ®Google Scholar
• Eshel A, Sharon I, Nagler A, Bomze D, Danylesko I, Fein JA, Geva M, Henig I, Shimoni A, Zuckerman T. et al. Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis. Blood Adv. 2022;6(2):568–573. doi:10.1182/bloodadvances.2021005110.
   PubMed Web of Science ®Google Scholar
• Abbas AA, Taylor LJ, Dothard MI, Leiby JS, Fitzgerald AS, Khatib LA, Collman RG, Bushman FD. Redondoviridae, a family of small, circular DNA viruses of the human oro-respiratory tract associated with periodontitis and critical illness. Cell Host Microbe. 2019;25(5):719–729.e4. doi:10.1016/j.chom.2019.04.001.
   PubMed Web of Science ®Google Scholar
• Kusakabe T, Lin W-Y, Cheong J-G, Singh G, Ravishankar A, Yeung ST, Mesko M, DeCelie MB, Carriche G, Zhao Z. et al. Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19. Nat Immunol. 2023;24(11):1879–1889. doi:10.1038/s41590-023-01637-4.
   PubMedGoogle Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–1031. doi:10.1038/nature05414.
   PubMed Web of Science ®Google Scholar
• Gordon JI, Dewey KG, Mills DA, Medzhitov RM. The human gut microbiota and undernutrition. Sci Transl Med. 2012;4(137):ps13712–ps13712. doi:10.1126/scitranslmed.3004347.
   Web of Science ®Google Scholar
• Wong SH, Zhao L, Zhang X, Nakatsu G, Han J, Xu W, Xiao X, Kwong TNY, Tsoi H, Wu WKK. et al. Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterology. 2017;153(6):1621–1633.e6. doi:10.1053/j.gastro.2017.08.022.
   PubMed Web of Science ®Google Scholar
• Branton D, Deamer DW, Marziali A, Bayley H, Benner SA, Butler T, Di Ventra M, Garaj S, Hibbs A, Huang X. et al. The potential and challenges of nanopore sequencing. Nat Biotechnol. 2008;26(10):1146–1153. doi:10.1038/nbt.1495.
   PubMed Web of Science ®Google Scholar
• Ma Z (Sam), Li W. How and why men and women differ in their microbiomes: medical ecology and network analyses of the microgenderome. Adv Sci. 2019;6(23):1902054. doi:10.1002/advs.201902054.
   Web of Science ®Google Scholar
• Yurkovetskiy L, Burrows M, Khan A, Graham L, Volchkov P, Becker L, Antonopoulos D, Umesaki Y, Chervonsky A. Gender bias in autoimmunity is influenced by microbiota. Immunity. 2013;39(2):400–412. doi:10.1016/j.immuni.2013.08.013.
   PubMed Web of Science ®Google Scholar
• Markle JGM, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD, Macpherson AJ, Danska JS. et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2013;339(6123):1084–1088. doi:10.1126/science.1233521.
   PubMed Web of Science ®Google Scholar
• Merdji H, Long MT, Ostermann M, Herridge M, Myatra SN, De Rosa S, Metaxa V, Kotfis K, Robba C, De Jong A. et al. Sex and gender differences in intensive care medicine. Intensive Care Med. 2023;49(10):1155–1167. doi:10.1007/s00134-023-07194-6.
   PubMed Web of Science ®Google Scholar